Digital Solutions
The Digital Solutions focus area offers strategic, technical, and financial insights to support the development and investment in products and solutions aligned with UPMC’s mission of advancing life-changing medicine. This team combines the expertise of investors, product managers, engineers, and designers to establish partnerships and create products that enhance patient-centered care while reducing costs.
At UPMC Enterprises, we provide our partners with a dynamic testing environment, allowing them to validate and refine their products and services within our health care system, covering a wide range of clinical and operational scenarios. We conduct pilot programs, assess product-market fit, and explore new market opportunities. Through our consulting services and software licensing models, we assist portfolio companies in solving challenges, fostering innovation, and achieving successful outcomes for patients, providers, and other stakeholders across the globe.
Keep scrolling to learn more.
By the Numbers
30+ portfolio companies and initiatives
2 full exits in 2023
Portfolio Highlights
Accelerating Growth with UPMC Enterprises’ Technology Services
Following thoughtful consideration, rigorous research, and in-depth analysis of the needs of health care technology companies and investment partners, the Technology Services team published a newly updated Technology Services catalog. This catalog outlines the team’s robust suite of services which have been meticulously designed to aid organizations throughout every phase of the health care technology venture life cycle.
Abridge Raises $30M to Accelerate Adoption of Its Proven Generative AI Solution Across U.S. Healthcare Systems
In the fourth quarter of 2023, Abridge announced a Series B raise of $30 million. This investment will support large-scale health system rollouts and accelerate product advances that will create additional value for patients, clinicians, and health systems.
Abridge Inks Epic Partnership, Emory Healthcare Tie-Up for Its Generative AI Tech
Abridge, the leader in generative AI for clinical documentation, is now the first Pal in Epic’s Partners and Pals program. The collaboration will make Abridge’s generative AI-based documentation solution available for integration in Epic’s clinical workflows, giving providers the ability to generate real-time, structured summaries of their patient conversations with complete auditability. Together, Abridge and Epic aim to help providers be more present and attentive to patients while also creating better notes, faster.
Unlocking the Power of Unstructured Data
Optimized for health care and trusted for over a decade, Alexandria Charts provides developers with a robust data platform and APIs to build and accelerate the next generation of health care solutions. This platform allows applications to finally unlock the 50-80% of patient data captured in unstructured clinical notes, progress notes, charts, narratives, and referral documents. Alexandria Charts makes it easy for teams to aggregate, normalize, comprehend, and transform unstructured data into high-quality, consumable data.
300,000+ documents processed per day in real time
400M+ total historical clinical documents stored
10M+ unique patient identities managed
Arrive Health Acquires UPMC’s Pharmacy Technology to Bring Automation to Pharmacy Outreach Workflows
With the goal of creating a first-of-its-kind pharmacy navigation network, Arrive Health has acquired a suite of innovative patient engagement and automation technologies developed by UPMC Enterprises and the UPMC Pharmacy Network. The technology, known at UPMC as UPMC Rx Express, supports pharmacy-patient outreach and conversation flows. The integrated workflow tools and AI chatbot help care teams prioritize patients who are at risk of skipping their medications and drive engagement through automated refill reminders. Arrive Health aims to improve access to the most affordable, quality care by delivering accurate, patient-specific cost and coverage data to providers, care teams, and patients.
Astrata Earns Certified Data Partner Designation in NCQA Data Aggregator Validation Program
Astrata earned Certified Data Partner designation in the new National Committee for Quality Assurance (NCQA) Data Aggregator Validation program. Astrata is part of the latest NCQA cohort to earn this NCQA certification, which indicates that Astrata adheres to strict data standards.
As one of the first of seven data partners to have achieved certification, Astrata is unique in its use of proprietary Natural Language Processing (NLP) transformations to earn NCQA’s rigorous assessment and certification. The company is certified for the Data Transformation, Normalization, and Mapping standard (PSD 4.0), using NLP methods to ensure that standard data streams include the full complement of applicable clinical data.
BrainCheck Joins athenahealth Marketplace
BrainCheck Inc. has recently become a part of the athenahealth® Marketplace, the largest app store for electronic health records (EHR). This integration broadens the reach of BrainCheck’s extensive cognitive assessment and care management platform to an expanding network of health care providers within athenahealth.
BrainCheck Expands First End-to-End Solution for Cognitive Care
In Q4 of 2023, BrainCheck introduced the next generation of its comprehensive platform, allowing easy access to patients’ cognitive health information from any device or location. The platform includes screening, assessment, care planning, and monitoring, aiming to make cognitive care more accessible and enable early diagnosis and intervention.
CarepathRx Health System Solutions and Evernorth Health Services Forge Strategic Partnership to Enhance Specialty Care for Patients
CarepathRx Health System Solutions (CHSS), a subsidiary of CarepathRx, and Evernorth Health Services, forged a strategic partnership marked by an investment from Evernorth into CHSS. This collaboration combines Evernorth’s extensive specialty and care knowledge with CHSS’ strong pharmacy and infusion management capabilities, technological solutions, and health system affiliations. The aim is to enhance, broaden, and expedite pharmacy care delivery for the increasing population of patients with chronic and complex care needs.
Clearsense Announces Success of $50M Capital Raise
Clearsense, a Platform as a Service (PaaS) provider collaborating with health care institutions to enhance data value, governance, and transparency, completed a $50 million Series D funding round. HealthQuest led the funding efforts, with continued support from existing investors, including Health Catalyst Capital and UPMC Enterprises.
New Study Suggests Tele-Infectious Diseases Care is an Effective Alternative to In-Person ID Care
A study in Open Forum Infectious Diseases conducted by UPMC in collaboration with Infectious Disease Connect, reveals Tele-Infectious Disease (ID) care as a compelling alternative to in-person ID care. The 642-person retrospective study demonstrates the following key outcomes: Tele-ID showed a substantial increase in patient evaluations (391 consultations compared to 251 for in-person ID), a slightly shorter average inpatient length of stay (3.9 days for Tele-ID versus 4.1 days for in-person ID), a decrease in readmissions, and a 4.7% reduction in antimicrobial usage (938 days of therapy per 1,000 patient-days compared to 984 for in-person ID care). This study underscores the potential of telemedicine to enhance health care accessibility and efficiency.
Moxe Health Receives 2023 Points of Light Award from KLAS Research
Moxe, a frontrunner in health care interoperability and clinical data exchange, was presented with a Points of Light Recognition Award by KLAS Research for its collaborative efforts with Humana and a prominent academic medical center. This marks the second consecutive year in which Moxe has earned this prestigious Points of Light award, underscoring the company’s consistent excellence in advancing health care interoperability and clinical data exchange.
Pip Care Signs Agreement with UChicago Medicine to Improve Surgical Outcomes and Drive Innovation
Pip Care, a company optimizing the surgical journey for care teams and patients, signed an agreement with UChicago Medicine, one of the nation’s leading integrated academic and community health systems. Launched in 2022, Pip Care partners with health systems to offer best-in-class care to patients throughout the surgical journey. This will be a first-of-its-kind service launched in the Chicago market. The first phase of the agreement includes a pilot of the Pip Care service.
Prodigo Solutions Acquired by Global Health Exchange
Prodigo Solutions, which aims to improve providers’ financial control and reduce supply chain cost, was acquired in April by Global Healthcare Exchange (GHX), a company focused on automating supply chain processes and improving visibility into the products used in patient care.
UPMC created Prodigo in 2008 with an essential mission to drive efficiencies and significant savings throughout the health system and supply chain. With proven success at UPMC over the years, Prodigo’s technology was adopted by other providers and health systems, allowing them to lower the costs of doing business with one another by making information more accessible and data more accurate.
Realyze Intelligence Expands Implementation and Visibility in the Marketplace
Realyze Intelligence, a company that uses artificial intelligence and natural language understanding (NLU) to analyze health care data, continued building relationships with leading cancer centers. The organization contributed insightful content to the Center for Connected Medicine’s report titled “Optimizing Clinical Trials at Health Systems,” published in June 2023. Additionally in 2023, leaders from Realyze presented at conferences including the AI & Robotics Venture Fair 2023 and Center for Connected Medicine’s Top of Mind for Life Sciences gathering.
Stanford Health CEO David Entwistle Joins Redesign Health’s Board
Distinguished health care executive and former CEO and president of Stanford Health Care David Entwistle has joined the board of directors at Redesign Health, a New York City-based health care startup creator and UPMC Enterprises portfolio company. Renowned for it’s track record, Redesign Health has successfully built and launched 50 health care startups since 2018, making it a key player in fostering innovative solutions in the health care sector. As a board member, Entwistle will help Redesign Health and its portfolio to expedite the journey from conceptualization to clinical implementation.
Nancy Cocozza Joins RxAnte Board of Directors
Industry veteran Nancy Cocozza, former senior vice president for CVS Aetna, has joined RxAnte as an independent member of the board of directors. For more than 30 years, Cocozza has been an innovator in the development and management of Medicare and prescription drug plans. Her expertise will help RxAnte continue to pioneer the field of value-based pharmacy care managed services.
Safar Telecare Continues Expansion Across the UPMC Footprint
Safar TeleCare is a web-based clinician-to-clinician communication and collaboration tool used to get specialized expertise to any bed, any time for any consults. In 2023, the Technology Services team focused on continued expansion of Safar across and within service lines with UPMC as well as commercial readiness. Accomplishments include the execution of a TeleTriage pilot to prove the value of remote ED triage and the impact on operations and patient satisfaction; implementation of usage tracking to facilitate data-driven feature decisions; integration with two EMRs; and rollout to numerous additional locations within UPMC as well as 13 non-UPMC locations.
700K+ days of healthy life saved in 2023
117% increase in TeleStroke volume in 2023
34K+ consults since TeleStroke launch
1.1M+ days of healthy life saved since TeleStroke launch
5,500+ users in more than 300 departments across UPMC
Sempre Health Secures $20 Million in Funding
Sempre Health, the forefront provider of behavior-based health care pricing solutions, secured an additional $20 million in funding. This round of investment includes notable contributions from three new investors, namely Cencora Ventures and Echo Health Ventures, alongside continued support from existing investors such as the Blue Venture Fund, UPMC Enterprises, and Industry Ventures.
Sempre’s SMS-based solution is addressing the pressing needs of millions of Americans grappling with the affordability of life-saving medications. Sempre’s impactful programs have proven instrumental in achieving a remarkable 20% enhancement in adherence rates.
Smile’s HDF platform uses industry-leading HDF architecture and ONC-compliant, event driven FHIR APIs to allow health care providers, payers, and IT vendors to build secure, composable, and scalable data infrastructures. Smile offers a suite of health data, clinical reasoning, and marketplace utilities that can support ecosystem-wide data innovation and digital modernization efforts to accelerate health care innovation, improve quality of patient care journeys, boost operational efficiencies, and reduce costs using intelligent automation implementation strategies.
sovaSage Unveils JeanieTM, the World’s First and Only Virtual Sleep Coach
In March, sovaSage Inc. unveiled their newest product, TherapistAssist JeanieTM. As the world’s first and only virtual sleep coach, JeanieTM uses a unique blend of artificial intelligence and clinical monitoring to transform the way durable medical equipment providers do business and increase patient compliance across the obstructive sleep apnea space.